Man who Picked Bitcoin at $428 Says "Buy Genesis"
He Picked Bitcoin (And Dogecoin) in 2016. What He's Recommending Now Could Turn Heads...
Watch more here!

OCUL Insider Trading (Ocular Therapeutix)

Insider Ownership Percentage: 3.60%
Insider Buying (Last 12 Months): $4,579.76
Insider Selling (Last 12 Months): $143,000.00

Ocular Therapeutix Insider Trading History Chart

Ocular Therapeutix Share Price & Price History

$14.45
▲ +0.02 (0.14%)
As of 06/11/2021 01:00 AM ET
Days: 30 | 90 | 365
Warren Buffett Just Poured $15 Billion Into This
Warren Buffett, Jeff Bezos, and Elon Musk are investing billions in a new trend.
Continue Reading
pixel

Ocular Therapeutix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2021Richard L Md LindstromDirectorSell10,000$14.30$143,000.0090,000View SEC Filing Icon  
10/16/2020Summer Road LlcMajor ShareholderBuy437$10.48$4,579.76View SEC Filing Icon  
5/19/2020Summer Road LlcMajor ShareholderBuy363,636$5.50$1,999,998.00View SEC Filing Icon  
3/24/2020Summer Road LlcMajor ShareholderBuy109,100$4.92$536,772.00View SEC Filing Icon  
3/19/2020Summer Road LlcMajor ShareholderBuy40,900$4.63$189,367.00View SEC Filing Icon  
3/17/2020Summer Road LlcMajor ShareholderBuy955,062$5.00$4,775,310.00View SEC Filing Icon  
3/13/2020Summer Road LlcMajor ShareholderBuy210,800$4.63$976,004.00View SEC Filing Icon  
1/2/2020Opaleye Management Inc.Major ShareholderBuy15,000$4.35$65,250.00View SEC Filing Icon  
12/30/2019Opaleye Management Inc.Major ShareholderBuy20,000$3.95$79,000.00
6/14/2019Donald NotmanCFOBuy2,500$4.33$10,825.00View SEC Filing Icon  
6/14/2019Leslie J WilliamsDirectorBuy4,500$4.40$19,800.004,500View SEC Filing Icon  
6/7/2019Amarpreet SawhneyChairmanBuy124,468$2.92$363,446.56990,563View SEC Filing Icon  
6/6/2019Antony C MattessichCEOBuy40,000$2.81$112,400.0097,900View SEC Filing Icon  
6/5/2019Amarpreet SawhneyChairmanBuy45,780$2.91$133,219.80898,711View SEC Filing Icon  
5/28/2019Michael H GoldsteinInsiderBuy12,000$2.51$30,120.0025,686View SEC Filing Icon  
3/15/2019Jeffrey S HeierDirectorBuy24,000$4.15$99,600.0024,000View SEC Filing Icon  
3/15/2019Michael H. GoldsteinInsiderBuy10,000$4.15$41,500.00View SEC Filing Icon  
3/13/2019Richard L Md LindstromDirectorBuy56,441$4.33$244,389.53100,000View SEC Filing Icon  
12/14/2018Kevin F HanleyInsiderBuy10,000$5.50$55,000.0020,000View SEC Filing Icon  
12/10/2018Kevin F HanleyInsiderBuy10,000$5.60$56,000.0010,000View SEC Filing Icon  
12/6/2018Daniel M BollagInsiderBuy17,400$5.76$100,224.00View SEC Filing Icon  
8/20/2018Antony C MattessichCEOBuy20,000$5.95$119,000.0057,900View SEC Filing Icon  
8/14/2018Donald NotmanCFOBuy12,500$6.29$78,625.0017,300View SEC Filing Icon  
8/10/2018Antony C MattessichInsiderBuy16,900$6.23$105,287.0037,900View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

61.90% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ocular Therapeutix Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/24/2021Principal Financial Group Inc.29,529$0.48M0.0%-2.8%0.039%Search for SEC Filing on Google Icon
5/21/2021Beacon Investment Advisory Services Inc.12,000$0.20M0.0%+20.0%0.016%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC15,938$0.26M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC20,026$0.33M0.0%+94.1%0.026%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC194,295$3.19M0.0%N/A0.255%Search for SEC Filing on Google Icon
5/18/2021Opaleye Management Inc.6,480,000$106.34M15.6%-0.5%8.494%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.652,128$10.70M0.0%-37.9%0.855%Search for SEC Filing on Google Icon
5/18/2021State of Wisconsin Investment Board101,800$1.67M0.0%+1.4%0.133%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley334,326$5.49M0.0%+27.6%0.438%Search for SEC Filing on Google Icon
5/18/2021Great Point Partners LLC1,007,012$16.53M3.4%+17.6%1.320%Search for SEC Filing on Google Icon
5/18/2021Dumac Inc.57,359$0.94M1.3%+52.7%0.075%Search for SEC Filing on Google Icon
5/18/2021Gotham Asset Management LLC24,438$0.40M0.0%-32.3%0.032%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC41,246$0.68M0.0%-21.7%0.054%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System109,936$1.80M0.0%+6.0%0.144%Search for SEC Filing on Google Icon
5/17/2021Endurant Capital Management LP438,933$7.20M1.9%+51.1%0.575%Search for SEC Filing on Google Icon
5/17/2021JS Capital Management LLC10,500$0.17M0.0%N/A0.014%Search for SEC Filing on Google Icon
5/17/2021Kamunting Street Capital Management L.P.436,307$7.16M2.8%+527.8%0.572%Search for SEC Filing on Google Icon
5/17/2021Fred Alger Management LLC70,477$1.16M0.0%-1.4%0.092%Search for SEC Filing on Google Icon
5/17/2021AQR Capital Management LLC65,077$1.07M0.0%+33.4%0.085%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada79,702$1.31M0.0%-7.1%0.104%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD32,901$0.54M0.0%+26.9%0.043%Search for SEC Filing on Google Icon
5/17/2021Ameriprise Financial Inc.11,290$0.19M0.0%-11.4%0.015%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC254,951$4.18M0.0%-57.6%0.334%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.637,749$10.47M0.0%+26.2%0.836%Search for SEC Filing on Google Icon
5/14/2021Brown Advisory Inc.90,000$1.48M0.0%N/A0.118%Search for SEC Filing on Google Icon
5/14/2021Castleark Management LLC485,837$7.97M0.3%+48.7%0.637%Search for SEC Filing on Google Icon
5/14/2021Rubric Capital Management LP382,386$6.28M0.4%N/A0.501%Search for SEC Filing on Google Icon
5/14/2021UBS Asset Management Americas Inc.62,448$1.03M0.0%+24.6%0.082%Search for SEC Filing on Google Icon
5/14/2021Dynamic Technology Lab Private Ltd20,828$0.34M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG42,797$0.70M0.0%-34.1%0.056%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP31,263$0.51M0.0%N/A0.041%Search for SEC Filing on Google Icon
5/13/2021SG Americas Securities LLC15,072$0.25M0.0%+39.8%0.020%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC65,631$1.08M0.0%+192.6%0.086%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC49,900$0.82M0.0%-85.1%0.065%Search for SEC Filing on Google Icon
5/13/2021Neuberger Berman Group LLC61,539$1.01M0.0%-3.2%0.081%Search for SEC Filing on Google Icon
5/13/2021Alpine Global Management LLC10,876$0.18M0.0%N/A0.014%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp257,917$4.23M0.0%-20.2%0.338%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.14,173$0.23M0.0%-34.0%0.019%Search for SEC Filing on Google Icon
5/13/2021Federated Hermes Inc.313,238$5.14M0.0%+25.8%0.411%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can3,397$56K0.0%-70.9%0.004%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp788,944$12.95M0.0%+0.9%1.034%Search for SEC Filing on Google Icon
5/12/2021Ergoteles LLC51,726$0.85M0.0%N/A0.068%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC1,229,608$20.18M0.0%+12.8%1.612%Search for SEC Filing on Google Icon
5/12/2021Lisanti Capital Growth LLC194,800$3.20M0.4%-46.8%0.255%Search for SEC Filing on Google Icon
5/12/2021Ensign Peak Advisors Inc59,711$0.98M0.0%+198.6%0.078%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.40,304$0.66M0.0%-50.8%0.053%Search for SEC Filing on Google Icon
5/12/2021Sei Investments Co.75,250$1.48M0.0%+34.1%0.099%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG550,864$9.04M0.0%-11.2%0.722%Search for SEC Filing on Google Icon
5/10/2021Nottingham Advisors Inc.194,266$3.19M0.4%-0.8%0.255%Search for SEC Filing on Google Icon
5/10/2021HighTower Advisors LLC11,284$0.19M0.0%-10.9%0.015%Search for SEC Filing on Google Icon
5/10/2021Principal Financial Group Inc.29,529$0.48M0.0%-2.8%0.039%Search for SEC Filing on Google Icon
5/10/2021Shell Asset Management Co.7,263$0.12M0.0%N/A0.010%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.5,867,062$96.28M0.0%+6.4%7.713%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.42,479$0.70M0.0%+6.5%0.056%Search for SEC Filing on Google Icon
5/7/2021BNP Paribas Arbitrage SA9,563$0.16M0.0%-28.5%0.013%Search for SEC Filing on Google Icon
5/7/2021Swiss National Bank138,600$2.27M0.0%+1.1%0.182%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers83,526$1.37M0.0%-2.6%0.110%Search for SEC Filing on Google Icon
5/6/2021Alliancebernstein L.P.86,600$1.42M0.0%+2.6%0.114%Search for SEC Filing on Google Icon
5/6/2021Altium Capital Management LP326,174$5.31M1.5%+7.6%0.429%Search for SEC Filing on Google Icon
5/4/2021Victory Capital Management Inc.1,548,627$25.41M0.0%+42.5%2.036%Search for SEC Filing on Google Icon
5/3/2021Zurcher Kantonalbank Zurich Cantonalbank10,665$0.18M0.0%+7.3%0.014%Search for SEC Filing on Google Icon
4/30/2021Creative Planning26,083$0.43M0.0%+10.5%0.034%Search for SEC Filing on Google Icon
4/29/2021Vigilare Wealth Management23,160$0.38M0.3%+71.2%0.030%Search for SEC Filing on Google Icon
4/29/2021Emerald Mutual Fund Advisers Trust1,353,896$22.22M0.7%+20.7%1.780%Search for SEC Filing on Google Icon
4/29/2021Emerald Advisers LLC1,294,850$21.25M0.8%+8.7%1.702%Search for SEC Filing on Google Icon
4/28/2021Spearhead Capital Advisors LLC20,281$0.33M0.0%N/A0.027%Search for SEC Filing on Google Icon
4/28/2021Lindbrook Capital LLC7,200$0.12M0.0%+92.1%0.009%Search for SEC Filing on Google Icon
4/26/2021GWM Advisors LLC13,780$0.23M0.0%-28.1%0.018%Search for SEC Filing on Google Icon
4/21/2021Deltec Asset Management LLC2,096,341$34.40M5.1%-3.3%2.756%Search for SEC Filing on Google Icon
3/16/2021Dumac Inc.37,567$0.78M0.6%N/A0.050%Search for SEC Filing on Google Icon
3/12/2021DekaBank Deutsche Girozentrale22,900$0.45M0.0%N/A0.030%Search for SEC Filing on Google Icon
3/10/2021Los Angeles Capital Management LLC13,410$0.28M0.0%N/A0.018%Search for SEC Filing on Google Icon
3/1/2021UBS Asset Management Americas Inc.50,137$1.04M0.0%N/A0.066%Search for SEC Filing on Google Icon
2/23/2021Principal Financial Group Inc.30,365$0.63M0.0%N/A0.040%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.81,880$1.70M0.0%-64.1%0.108%Search for SEC Filing on Google Icon
2/17/2021Voloridge Investment Management LLC24,060$0.50M0.0%N/A0.032%Search for SEC Filing on Google Icon
2/17/2021Castleark Management LLC326,642$6.76M0.3%N/A0.431%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC10,315$0.21M0.0%-91.2%0.014%Search for SEC Filing on Google Icon
2/16/2021Morgan Stanley261,917$5.42M0.0%-1.0%0.345%Search for SEC Filing on Google Icon
2/16/2021Endurant Capital Management LP290,465$6.01M2.2%-65.3%0.383%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC600,671$12.43M0.0%+143.5%0.792%Search for SEC Filing on Google Icon
2/16/2021Price T Rowe Associates Inc. MD25,928$0.54M0.0%N/A0.034%Search for SEC Filing on Google Icon
2/16/2021ETF Managers Group LLC59,796$1.22M0.0%N/A0.079%Search for SEC Filing on Google Icon
2/16/2021Engineers Gate Manager LP32,991$0.68M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/16/2021Avidity Partners Management LP250,000$5.18M0.2%N/A0.330%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.168,640$3.49M0.0%+14.3%0.222%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.39,872$0.83M0.0%+10.2%0.053%Search for SEC Filing on Google Icon
2/12/2021Opaleye Management Inc.6,510,000$134.76M17.6%+8.8%8.581%Search for SEC Filing on Google Icon
2/12/2021Penserra Capital Management LLC1,640$33K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.248,911$5.15M0.0%+118,996.2%0.328%Search for SEC Filing on Google Icon
2/12/2021Raymond James Financial Services Advisors Inc.24,890$0.52M0.0%+18.4%0.033%Search for SEC Filing on Google Icon
2/12/2021Amalgamated Bank10,662$0.22M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/12/2021The Manufacturers Life Insurance Company40,819$0.85M0.0%+18.2%0.054%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG64,955$1.34M0.0%N/A0.086%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp781,570$16.18M0.0%+14.6%1.030%Search for SEC Filing on Google Icon
2/11/2021Barclays PLC22,428$0.46M0.0%-26.3%0.030%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.21,483$0.45M0.0%-3.2%0.028%Search for SEC Filing on Google Icon
2/11/2021Monashee Investment Management LLC60,000$1.24M0.2%N/A0.079%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers85,715$1.77M0.0%+21.2%0.113%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC334,066$6.92M0.0%N/A0.440%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ocular Therapeutix logo
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant administered by the fine-gauge needle that is in phase 1 clinical trial for the treatment of wet age-related macular degeneration; OTX-TIC, a travoprost intracameral implant, which is in phase 1 clinical trial for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that is in phase 2 clinical trial for the chronic treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trial for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company is involved in the development of OTX-AFS, an aflibercept suprachoroidal injection for the treatment of retinal diseases. It has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Read More on Ocular Therapeutix

Today's Range

Now: $14.45
$14.10
$14.54

50 Day Range

MA: $15.47
$13.75
$19.16

52 Week Range

Now: $14.45
$7.14
$24.30

Volume

450,023 shs

Average Volume

1,045,927 shs

Market Capitalization

$1.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.15

Who are the company insiders with the largest holdings of Ocular Therapeutix?

Ocular Therapeutix's top insider investors include:
  1. Richard L Md Lindstrom (Director)
  2. Leslie J Williams (Director)
  3. Donald Notman (CFO)
  4. Opaleye Management Inc (Major Shareholder)
  5. Summer Road Llc (Major Shareholder)

Who are the major institutional investors of Ocular Therapeutix?

Ocular Therapeutix's top institutional investors include:
  1. Opaleye Management Inc. — 8.49%
  2. BlackRock Inc. — 7.71%
  3. Deltec Asset Management LLC — 2.76%
  4. Victory Capital Management Inc. — 2.04%
  5. Emerald Mutual Fund Advisers Trust — 1.78%
  6. Emerald Advisers LLC — 1.70%

Which major investors are selling Ocular Therapeutix stock?

In the previous quarter, OCUL stock was sold by these institutional investors:
  1. D. E. Shaw & Co. Inc.
  2. Nuveen Asset Management LLC
  3. Renaissance Technologies LLC
  4. Lisanti Capital Growth LLC
  5. Deltec Asset Management LLC
  6. UBS Group AG
  7. Bank of New York Mellon Corp
  8. JPMorgan Chase & Co.

Which major investors are buying Ocular Therapeutix stock?

In the previous quarter, OCUL stock was purchased by institutional investors including:
  1. Victory Capital Management Inc.
  2. Rubric Capital Management LP
  3. Kamunting Street Capital Management L.P.
  4. BlackRock Inc.
  5. Emerald Mutual Fund Advisers Trust
  6. Millennium Management LLC
  7. Castleark Management LLC
  8. Great Point Partners LLC
During the previous year, these company insiders have bought Ocular Therapeutix stock:
  1. Richard L Md Lindstrom (Director)
  2. Leslie J Williams (Director)
  3. Donald Notman (CFO)
  4. Opaleye Management Inc (Major Shareholder)
Man Who Picked Tesla, Bitcoin Makes Next “Pick of the Decade"
Picking the right “investment of the decade” can transform your life…

Today, the Wall Street legend who picked the last “investment of the decade”… months (even years) before his peers… will finally reveal his new #1 pick for the 2020s.

It’s not 5G, artificial intelligence, EVs, or clean energy. The answer will surprise you.
Click To See This #1 Pick.